Finance

Lists
Q3 2026 earnings • released • EPS beat +16.14% • Revenue beat +3.15%
See results
LIVN:NASDAQ
LivaNova PLC
$91.14
0.00%
(0.00) 1D
Nov 5, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LIVN...
Mkt. cap
5.02B
Avg. vol.
725.38K
Volume
1.35K
P/E ratio
26.10
52-wk high
$99.38
52-wk low
$48.82
EPS
$3.49
Beta
0.91
Shares outstanding
55.09M
No. of employees
3K
Mkt. cap
5.02B
Avg. vol.
725.38K
Volume
1.35K
P/E ratio
26.10
52-wk high
$99.38
52-wk low
$48.82
EPS
$3.49
Beta
0.91
Shares outstanding
55.09M
No. of employees
3K
News stories
From web sources and news partners
Profile
LivaNova, plc is a medical device manufacturer that is a foreign domiciled company based in the U.K. for tax inversion purposes. With operational headquarters in the United States. The company develops devices used for cardiac surgery and neuromodulation. The company was formed in 2015 by a $2.7B merger between Houston, Texas-based Cyberonics, Inc. and Milan, Italy-based Sorin S.p.a. The company trades on the NASDAQ stock exchange under the ticker symbol "LIVN". Wikipedia
About LivaNova PLC
CEOVladimir Makatsaria
Employees3.3K
Founded1987
Headquarters-
SectorHealth Care
IndustryMedical device
Websitelivanova.com
Analyst ratings
Based on 7 analysts giving stock ratings to LIVN in the past 3 months
Strong buy
Buy
6
Hold
1
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for LIVN in the last 3 months.
Highest
Current $91.14
$120.00 (+31.67%)
Average
$104.00 (+14.11%)
Lowest
$75.00 (-17.71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Anthony Petrone
Mizuho Securities
Buy
Maintained
$115.00
+26.2%
11/05/2026
David Rescott
Robert W. Baird
Buy
Maintained
$111.00
+21.8%
11/05/2026
Christopher Pasquale
Barclays
Buy
Maintained
$105.00
+15.2%
11/05/2026
Matthew Taylor
Jefferies
Buy
Reiterated
$120.00
+31.7%
11/04/2026
Michael Matson
Needham
Buy
Maintained
$112.00
+22.9%
11/04/2026
Matt Miksic
Barclays
Buy
Maintained
$105.00
+15.2%
10/07/2026
Adam Maeder
Piper Sandler
Buy
Reiterated
$90.00
-1.3%
09/02/2026
Keith Hinton
Freedom Capital Markets
Hold
Maintained
$75.00
-17.7%
08/20/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
$85.00
-6.7%
08/05/2026
Brett Fishbin
KeyBanc
Buy
Reiterated
$92.00
+0.9%
06/22/2026
David Roman
Goldman Sachs
Hold
Maintained
$72.00
-21%
05/06/2026
Last report
Nov 4, 2026
Fiscal period
Q3 2026
$1.23 / $1.06
+16.14%beat
Revenue / Est. (USD)
393.10M / 381.11M
+3.15%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
360.92M
362.26M
390.59M
393.10M
Cost of goods sold
120.05M
117.41M
125.62M
128.10M
Cost of revenue
120.05M
117.41M
125.62M
128.10M
Research and development expenses
48.52M
49.14M
52.86M
47.70M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
143.66M
143.57M
158.13M
154.90M
Operating expense
194.07M
192.71M
212.07M
236.60M
Total operating expenses
314.12M
310.12M
337.68M
364.70M
Operating income
46.81M
52.14M
52.90M
28.40M
Other non operating income
378.36M
-7.53M
-38.73M
100.00K
EBT including unusual items
27.62M
26.63M
18.36M
46.70M
EBT excluding unusual items
393.28M
38.44M
8.14M
46.70M
Income tax expense
-3.28M
4.34M
-90.20M
12.40M
Effective tax rate
-11.88%
16.29%
-491.17%
26.55%
Other operating expenses
1.88M
-
1.08M
34.00M
Net income
30.91M
22.29M
108.57M
34.30M
Net profit margin
8.56%
6.15%
27.80%
8.73%
Earnings per share
0.86
0.98
1.26
1.23
Interest and investment income
4.46M
3.55M
3.83M
-
Interest expense
-10.86M
-8.29M
-7.18M
-8.00M
Net interest expenses
-6.40M
-4.74M
-3.34M
-8.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
58.88M
65.00M
68.32M
43.92M
Gain or loss from assets sale
-4.13M
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps